Trial Profile

A clinical study of IL-17 NanoAb for treatment of psoriasis

Status: Planning

Phase of Trial: Phase I/II

Latest Information Update: 16 Dec 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

02 Dec 2025 According to a Scinai Immunotherapeutics media release, the company is progressing toward entry into a phase 1/2a clinical trial, supported by translational data, with a decision on its 15 million dollar EU STEP grant application expected in Q1 2026.
29 Nov 2024 Planned initiation date changed to 1 Jul 2025.
22 Nov 2024 According to Scinai media release, trial is expected to commence in the second half of 2025 with readout in 2026.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com